Juergen Engel

1.7k total citations · 1 hit paper
21 papers, 1.3k citations indexed

About

Juergen Engel is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Juergen Engel has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Juergen Engel's work include Research on Leishmaniasis Studies (5 papers), Prostate Cancer Treatment and Research (4 papers) and Metal complexes synthesis and properties (3 papers). Juergen Engel is often cited by papers focused on Research on Leishmaniasis Studies (5 papers), Prostate Cancer Treatment and Research (4 papers) and Metal complexes synthesis and properties (3 papers). Juergen Engel collaborates with scholars based in United States, Germany and Malaysia. Juergen Engel's co-authors include H. Sindermann, C.P. Thakur, A.D.M. Bryceson, T. K. Jha, Shyam Sundar, Klaus Junge, Simon L. Croft, Christina Fischer, Jonathan Berman and H. SCHOENENBERGER and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Clinical Infectious Diseases.

In The Last Decade

Juergen Engel

21 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral Miltefosine for Indian Visceral Leishmaniasis

2002 568 citations Shyam Sundar, T. K. Jha et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juergen Engel United States	13	710	391	335	281	162	21	1.3k
Sara Ghorashian United Kingdom	17	344 0.5×	381 1.0×	436 1.3×	138 0.5×	233 1.4×	39	1.5k
H. Sindermann Germany	23	1.6k 2.3×	911 2.3×	606 1.8×	398 1.4×	100 0.6×	40	2.4k
Joel V. Tuttle United States	18	155 0.2×	445 1.1×	889 2.7×	154 0.5×	35 0.2×	22	1.3k
Steven S. Good United States	21	104 0.1×	1.0k 2.6×	739 2.2×	186 0.7×	465 2.9×	43	2.5k
Yuko Ogata United States	20	487 0.7×	497 1.3×	662 2.0×	28 0.1×	37 0.2×	47	1.6k
Philip Reyes United States	19	160 0.2×	255 0.7×	763 2.3×	66 0.2×	42 0.3×	35	1.2k
Thomas P. Zimmerman United States	26	135 0.2×	518 1.3×	1.1k 3.4×	135 0.5×	120 0.7×	68	2.1k
Subhendu Das United States	18	79 0.1×	448 1.1×	733 2.2×	201 0.7×	49 0.3×	26	1.4k
Mary Sue Colemán United States	25	354 0.5×	457 1.2×	1.3k 4.0×	47 0.2×	220 1.4×	79	2.1k
Kodjo Ayi Canada	19	524 0.7×	278 0.7×	270 0.8×	17 0.1×	35 0.2×	23	1.4k

Countries citing papers authored by Juergen Engel

Since Specialization

Citations

This map shows the geographic impact of Juergen Engel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juergen Engel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juergen Engel more than expected).

Fields of papers citing papers by Juergen Engel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juergen Engel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juergen Engel. The network helps show where Juergen Engel may publish in the future.

Co-authorship network of co-authors of Juergen Engel

This figure shows the co-authorship network connecting the top 25 collaborators of Juergen Engel. A scholar is included among the top collaborators of Juergen Engel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juergen Engel. Juergen Engel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arcari, Luca, Juergen Engel, Tilo Freiwald, et al.. (2021). Cardiac biomarkers in chronic kidney disease are independently associated with myocardial edema and diffuse fibrosis by cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance. 23(1). 71–71. 23 indexed citations

Arcari, Luca, Rocío Hinojar, Juergen Engel, et al.. (2020). Native T1 and T2 provide distinctive signatures in hypertrophic cardiac conditions – Comparison of uremic, hypertensive and hypertrophic cardiomyopathy. International Journal of Cardiology. 306. 102–108. 39 indexed citations

Arcari, Luca, Juergen Engel, Tilo Freiwald, et al.. (2019). Aortic stiffness is independently associated with interstitial myocardial fibrosis by native T1 and accelerated in the presence of chronic kidney disease. IJC Heart & Vasculature. 24. 100389–100389. 18 indexed citations

Liu, Stephen V., Denice Tsao‐Wei, Shigang Xiong, et al.. (2014). Phase I, Dose-Escalation Study of the Targeted Cytotoxic LHRH Analog AEZS-108 in Patients with Castration- and Taxane-Resistant Prostate Cancer. Clinical Cancer Research. 20(24). 6277–6283. 37 indexed citations

Fensterle, Joachim, et al.. (2014). Current View on the Mechanism of Action of Perifosine in Cancer. Anti-Cancer Agents in Medicinal Chemistry. 14(4). 629–635. 33 indexed citations

Pinski, Jacek, Andrew V. Schally, Denice Tsao‐Wei, et al.. (2013). A phase I dose-escalation trial of AEZS-108 in taxane- and castration-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 31(15_suppl). 5062–5062. 1 indexed citations

Aicher, Babette, Rolf Jansen, Herbert Irschik, et al.. (2011). Abstract C214: Disorazol Z: A highly cytotoxic natural compound with antitumor properties.. Molecular Cancer Therapeutics. 10(11_Supplement). C214–C214. 5 indexed citations

Liu, Stephen V., Andrew V. Schally, Debra Hawes, et al.. (2010). Expression of Receptors for Luteinizing Hormone-Releasing Hormone (LH-RH) in Prostate Cancers following Therapy with LH-RH Agonists. Clinical Cancer Research. 16(18). 4675–4680. 41 indexed citations

Engel, Juergen, Andrew V. Schally, Balázs Dezsö, et al.. (2008). LUTEINIZING HORMONE-RELEASING HORMONE (LHRH) RECEPTORS IN BPH AS POTENTIAL MOLECULAR TARGETS FOR THERAPY WITH CETRORELIX. The Journal of Urology. 179(4S). 449–450. 1 indexed citations

10.

Engel, Juergen, et al.. (2007). Comparative preclinical antiproliferative activity of lobaplatin vs cisplatin, carboplatin, oxaliplatin and satraplatin in breast and ovarian cancers. 67. 4780–4780. 3 indexed citations

11.

Croft, Simon L. & Juergen Engel. (2006). Miltefosine – discovery of the antileishmanial activity of phospholipid derivatives. Transactions of the Royal Society of Tropical Medicine and Hygiene. 100. S4–S8. 128 indexed citations

12.

Zerpa, Olga, et al.. (2006). Treatment of diffuse cutaneous leishmaniasis with miltefosine: a case report. International Journal of Dermatology. 45(6). 751–753. 14 indexed citations

13.

Bhattacharya, Sujit, T. K. Jha, Shyam Sundar, et al.. (2004). Efficacy and Tolerability of Miltefosine for Childhood Visceral Leishmaniasis in India. Clinical Infectious Diseases. 38(2). 217–221. 110 indexed citations

14.

Sundar, Shyam, T. K. Jha, C.P. Thakur, et al.. (2002). Oral Miltefosine for Indian Visceral Leishmaniasis. New England Journal of Medicine. 347(22). 1739–1746. 568 indexed citations breakdown →

15.

Sundar, Shyam, T. K. Jha, C.P. Thakur, et al.. (2002). Oral Miltefosine for Indian visceral leishmaniasis. N Engl J Med. 3 indexed citations

16.

Engel, Juergen, et al.. (2000). Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome. Journal of Medical Genetics. 37(12). 921–926. 139 indexed citations

17.

Engel, Juergen, et al.. (1990). Chemistry and pharmacology of the non-benzodiazepine anxiolytic enciprazine and related compounds. Journal of Medicinal Chemistry. 33(11). 2976–2981. 6 indexed citations

18.

Gust, Ronald, Thilo Spruß, M. R. Schneider, et al.. (1988). Ring-substituted [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) complexes: compounds with a selective effect on the hormone-dependent mammary carcinoma. Journal of Medicinal Chemistry. 31(1). 72–83. 80 indexed citations

19.

Engel, Juergen, et al.. (1986). Alifedrine. Cardiovascular Drug Reviews. 4(1). 41–62. 1 indexed citations

20.

Jennerwein, Margaretha, et al.. (1984). Dichloro[1,2-bis(4-hydroxyphenyl)ethylenediamine]platinum(II) complexes: an approach to develop compounds with a specific effect on the hormone-dependent mammary carcinoma. Journal of Medicinal Chemistry. 27(10). 1280–1286. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact